PE79999A1 - Derivados de macrolidos c-4" sustituidos - Google Patents
Derivados de macrolidos c-4" sustituidosInfo
- Publication number
- PE79999A1 PE79999A1 PE1998000469A PE00046998A PE79999A1 PE 79999 A1 PE79999 A1 PE 79999A1 PE 1998000469 A PE1998000469 A PE 1998000469A PE 00046998 A PE00046998 A PE 00046998A PE 79999 A1 PE79999 A1 PE 79999A1
- Authority
- PE
- Peru
- Prior art keywords
- alkyl
- alkynyl
- hydroxy
- heteroaryl
- polyclic
- Prior art date
Links
- 239000003120 macrolide antibiotic agent Substances 0.000 title 1
- 229940041033 macrolides Drugs 0.000 title 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical class [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 abstract 3
- 229920006395 saturated elastomer Polymers 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- DBTDEFJAFBUGPP-UHFFFAOYSA-N Methanethial Chemical group S=C DBTDEFJAFBUGPP-UHFFFAOYSA-N 0.000 abstract 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical class O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 abstract 1
- -1 OXAZOLYL Chemical class 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical group 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
SE REFIERE A UN COMPUESTO DE FORMULA (I), DONDE X ES -CH(NR9R10)-, -C(O), C(=NOR9)-, ENTRE OTROS; R1 ES H, HIDROXI o METOXI; R2 ES HIDROXI; R3 ES ALQUILO C1-C10, -CH2S(O)nR8, -(CH2)m(ARILO C6-C10), n ES 0-2, m ES 0-4; o R2 Y R3 FORMAN UN OXAZOLILO DE FORMULA (a); R4 ES H, -C(O)R9, -C(O)NR9R10; R5 ES SR8, -(CH2)nC(O)R8, ALQUILO C1-C10, ALQUENILO C2-C10, ENTRE OTROS, R6 Y R7 SON H, HIDROXI, ALCOXI C1-C6, ENTRE OTROS; R8 ES H, ALQUILO C1-C10, -(CH2)qCR11CR12(CH2)rNR13R14, q Y r SON 0-3 PERO NO SON AMBOS CERO, R8 ES -CH2NR8R15, R15 Y R8 FORMAN UN ANILLO SATURADO DE 4-10 MIEMBROS o POLICICLICO SATURADO o HETEROARILO DE 5-10 MIEMBROS CON 1-2 O, S, N(R8); CADA R9 Y R10 SON H o ALQUILO C1-C6; R11, R12, R13 Y R14 SON H o ALQUILO C1-C10, -(CH2)m(ARILO C6-C10) Y (CH2)m(HETEROARILO DE 5-10 MIEMBROS); o R11 Y R13 FORMAN JUNTOS -(CH2)p-, p ES 0-3 o R13 Y R14 FORMAN UN ANILLO SATURADO MONO O POLICICLICO DE 4-10 MIEMBROS o UN HETEROARILO DE 5-10 MIEMBROS CON 1-2 O, S Y -N(R8)-; R15 ES H, ALQUILO C1-C10, ALQUENILO C2-10 o ALQUINILO C2-C10; R16 ES HALOGENO, CIANO, NITRO, ENTRE OTROS; R17 ES H, ALQUILO C1-C10, ALQUENILO C2-C10, ENTRE OTROS; CUANDO R3 ES CH2S(O)nR8, R8 NO ES H. TAMBIEN SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACION. EL COMPUESTO I PUEDE SER UTIL PARA EL TRATAMIENTO DE UNA INFECCION BACTERIANA O PROTOZOARIA
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4998097P | 1997-06-11 | 1997-06-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE79999A1 true PE79999A1 (es) | 1999-08-25 |
Family
ID=21962765
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1998000469A PE79999A1 (es) | 1997-06-11 | 1998-06-08 | Derivados de macrolidos c-4" sustituidos |
Country Status (39)
| Country | Link |
|---|---|
| EP (1) | EP0988309B1 (es) |
| JP (1) | JP3262806B2 (es) |
| KR (1) | KR100369959B1 (es) |
| CN (1) | CN1145636C (es) |
| AP (1) | AP1189A (es) |
| AR (1) | AR013085A1 (es) |
| AT (1) | ATE310742T1 (es) |
| AU (1) | AU745006C (es) |
| BG (1) | BG64357B1 (es) |
| BR (1) | BR9810097A (es) |
| CA (1) | CA2293397C (es) |
| CO (1) | CO4950584A1 (es) |
| DE (1) | DE69832486T2 (es) |
| DZ (1) | DZ2515A1 (es) |
| EA (1) | EA002440B1 (es) |
| ES (1) | ES2251081T3 (es) |
| GT (1) | GT199800075A (es) |
| HN (1) | HN1998000074A (es) |
| HR (1) | HRP980315A2 (es) |
| HU (1) | HUP0004076A3 (es) |
| ID (1) | ID24530A (es) |
| IL (1) | IL132808A (es) |
| IS (1) | IS1979B (es) |
| MA (1) | MA24563A1 (es) |
| MY (1) | MY133027A (es) |
| NO (1) | NO315560B1 (es) |
| NZ (1) | NZ500652A (es) |
| OA (1) | OA11226A (es) |
| PA (1) | PA8452001A1 (es) |
| PE (1) | PE79999A1 (es) |
| PL (1) | PL337497A1 (es) |
| SK (1) | SK168299A3 (es) |
| TN (1) | TNSN98084A1 (es) |
| TW (2) | TW200418871A (es) |
| UA (1) | UA70298A (es) |
| UY (1) | UY25041A1 (es) |
| WO (1) | WO1998056801A1 (es) |
| YU (1) | YU62999A (es) |
| ZA (1) | ZA985016B (es) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ502861A (en) * | 1997-09-10 | 2001-03-30 | Merck & Co Inc | Method of treating livestock bacterial respiratory or enteric infections using 9a-azalides |
| US6339063B1 (en) | 1997-09-10 | 2002-01-15 | Merck & Co., Inc. | 9a-azalides as veterinary antimicrobial agents |
| EP1779853A3 (en) * | 1997-09-10 | 2010-01-27 | Merial Ltd. | 9a-azalides as veterinary antimicrobial agents |
| AP9801420A0 (en) * | 1998-01-02 | 1998-12-31 | Pfizer Prod Inc | Novel macrolides. |
| US6043227A (en) * | 1998-08-19 | 2000-03-28 | Pfizer Inc. | C11 carbamates of macrolide antibacterials |
| EP1437360A3 (en) * | 1998-08-19 | 2005-04-06 | Pfizer Products Inc. | C11 Carbamates of macrolide antibacterials |
| US6100240A (en) * | 1998-10-09 | 2000-08-08 | Pfizer Inc | Macrolide derivatives |
| KR20010083944A (ko) | 1998-11-03 | 2001-09-03 | 실버스타인 아써 에이. | 신규 마크롤라이드 항생물질 |
| CA2292359C (en) * | 1999-01-28 | 2004-09-28 | Pfizer Products Inc. | Novel azalides and methods of making same |
| DE60025370T2 (de) * | 1999-08-24 | 2006-09-21 | Abbott Laboratories, Abbott Park | 9a-azalide mit antibakterieller wirkung |
| US6764996B1 (en) | 1999-08-24 | 2004-07-20 | Abbott Laboratories | 9a-azalides with antibacterial activity |
| JP3893059B2 (ja) | 2000-01-27 | 2007-03-14 | ファイザー・プロダクツ・インク | アザライド系抗生物質組成物 |
| BR0209241A (pt) * | 2001-04-27 | 2004-06-15 | Pfizer Prod Inc | Processo para preparação de derivados de9-deoxo-9a-aza-9a-homoeritromicina a 4-substituida |
| JP2003040782A (ja) * | 2001-05-31 | 2003-02-13 | Pfizer Prod Inc | アザリド抗生物質組成物 |
| ES2325495T3 (es) | 2002-07-08 | 2009-09-07 | Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. | Moleculas hibridas de macrolidos con moleculas anti-inflamatorias esteroideas y no esteroideas. |
| RU2330858C2 (ru) | 2002-07-08 | 2008-08-10 | Глаксомитклайн Истраживацки Центар Загреб Д.О.О. | Новые соединения, составы и способы лечения воспалительных заболеваний и состояний |
| US7109176B2 (en) * | 2002-07-08 | 2006-09-19 | Pliva-Istrazivacki Institut D.O.O. | Nonsteroidal anti-inflammatory substances, compositions and methods for their use |
| AR043050A1 (es) | 2002-09-26 | 2005-07-13 | Rib X Pharmaceuticals Inc | Compuestos heterociclicos bifuncionales y metodos para preparar y usar los mismos |
| EP1638549A4 (en) * | 2003-03-10 | 2011-06-15 | Optimer Pharmaceuticals Inc | NEW ANTIBACTERIAL AGENTS |
| US7276487B2 (en) | 2003-09-23 | 2007-10-02 | Enanta Pharmaceuticals, Inc. | 9a, 11-3C-bicyclic 9a-azalide derivatives |
| EP2716647A3 (en) | 2004-02-27 | 2014-08-20 | Rib-X Pharmaceuticals, Inc. | Macrocyclic compounds and methods of making and using the same |
| JPWO2009019868A1 (ja) | 2007-08-06 | 2010-10-28 | 大正製薬株式会社 | １０ａ、１２位架橋型１０ａ−アザライド化合物 |
| EP2214484A4 (en) | 2007-10-25 | 2013-01-02 | Cempra Pharmaceuticals Inc | PROCESS FOR PREPARING ANTIBACTERIAL MAKROLIDE AGENTS |
| EP2287173A4 (en) | 2008-05-15 | 2013-06-19 | Taisho Pharmaceutical Co Ltd | 10A AZALIDE COMPOUND WITH 4-LOW RING STRUCTURE |
| ES2677007T3 (es) | 2008-10-24 | 2018-07-27 | Cempra Pharmaceuticals, Inc. | Procedimientos para tratar enfermedades resistentes usando macrólidos que contienen triazol |
| US9937194B1 (en) | 2009-06-12 | 2018-04-10 | Cempra Pharmaceuticals, Inc. | Compounds and methods for treating inflammatory diseases |
| WO2012038372A1 (en) * | 2010-09-20 | 2012-03-29 | Novartis Ag | Novel process for the preparation of 9-deoxo-9a-aza- 9a-homoerythromycin a modified in the c-4'' of the cladinose ring by an epoxide group |
| AR085286A1 (es) * | 2011-02-21 | 2013-09-18 | Taisho Pharmaceutical Co Ltd | Derivado de macrolido sustituido en la posicion c-4 |
| NZ700182A (en) | 2012-03-27 | 2017-02-24 | Cempra Pharmaceuticals Inc | Parenteral formulations for administering macrolide antibiotics |
| JP5857008B2 (ja) * | 2012-08-20 | 2016-02-10 | 大正製薬株式会社 | Ｃ−４”位置換マクロライド誘導体を含有する医薬 |
| JP6437523B2 (ja) | 2013-04-04 | 2018-12-12 | プレジデント アンド フェローズ オブ ハーバード カレッジ | マクロライドならびにそれらの調製および使用の方法 |
| CN103965273B (zh) * | 2013-08-23 | 2016-05-25 | 普莱柯生物工程股份有限公司 | 一种大环内酯类化合物 |
| CN105669798B (zh) * | 2013-08-23 | 2019-07-26 | 普莱柯生物工程股份有限公司 | 一种大环内酯类化合物 |
| AR102810A1 (es) | 2014-08-18 | 2017-03-29 | Taisho Pharmaceutical Co Ltd | Derivado de macrólido sustituido en la posición c-4 |
| HK1242920A1 (zh) | 2014-10-08 | 2018-07-06 | 哈佛大学的校长及成员们 | 14-元酮内酯及其制备和使用方法 |
| HK1250371A1 (zh) | 2015-03-25 | 2018-12-14 | President And Fellows Of Harvard College | 具有修饰的脱氧糖胺糖的大环内酯及其用途 |
| CN108003207B (zh) | 2017-12-19 | 2019-05-10 | 海门慧聚药业有限公司 | 制备泰拉霉素的方法 |
| MX2022011242A (es) * | 2020-03-12 | 2022-12-15 | Zoetis Services Llc | Inmunomodulación de o-het/aril azálidos. |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE445223B (sv) * | 1977-02-04 | 1986-06-09 | Pfizer | Sett att framstella 4"-amino-erytomylin-a-derivat |
| US4150220A (en) * | 1977-02-04 | 1979-04-17 | Pfizer Inc. | Semi-synthetic 4"-erythromycin A derivatives |
| YU43006B (en) * | 1981-03-06 | 1989-02-28 | Pliva Pharm & Chem Works | Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof |
| US4474768A (en) * | 1982-07-19 | 1984-10-02 | Pfizer Inc. | N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor |
| GR80277B (en) * | 1983-09-06 | 1985-01-04 | Pfizer | Azahomoerythromycin b derivatives and intermediates therefor |
| US4512982A (en) * | 1984-04-13 | 1985-04-23 | Pfizer Inc. | 9α-Aza-9α-homoerythromycin compounds, pharmaceutical composition and therapeutic method |
| CA2064634C (en) * | 1991-04-04 | 1998-08-04 | James V. Heck | 9-deoxo-8a-aza-8a-homoerythromycin a derivatives modified at the 4"- and8a-positions |
| US5441939A (en) * | 1994-03-04 | 1995-08-15 | Pfizer Inc. | 3"-desmethoxy derivatives of erythromycin and azithromycin |
| US5412982A (en) * | 1994-03-10 | 1995-05-09 | Potts; James K. | Windsock support |
-
1998
- 1998-05-20 HN HN1998000074A patent/HN1998000074A/es unknown
- 1998-05-22 PA PA19988452001A patent/PA8452001A1/es unknown
- 1998-05-25 ES ES98919414T patent/ES2251081T3/es not_active Expired - Lifetime
- 1998-05-25 SK SK1682-99A patent/SK168299A3/sk unknown
- 1998-05-25 IL IL13280898A patent/IL132808A/en not_active IP Right Cessation
- 1998-05-25 KR KR10-1999-7011643A patent/KR100369959B1/ko not_active Expired - Fee Related
- 1998-05-25 EA EA199901014A patent/EA002440B1/ru not_active IP Right Cessation
- 1998-05-25 YU YU62999A patent/YU62999A/sh unknown
- 1998-05-25 AU AU72281/98A patent/AU745006C/en not_active Ceased
- 1998-05-25 WO PCT/IB1998/000799 patent/WO1998056801A1/en not_active Ceased
- 1998-05-25 ID IDW991565A patent/ID24530A/id unknown
- 1998-05-25 EP EP98919414A patent/EP0988309B1/en not_active Expired - Lifetime
- 1998-05-25 BR BR9810097-1A patent/BR9810097A/pt not_active IP Right Cessation
- 1998-05-25 JP JP50192999A patent/JP3262806B2/ja not_active Expired - Fee Related
- 1998-05-25 CA CA002293397A patent/CA2293397C/en not_active Expired - Fee Related
- 1998-05-25 DE DE69832486T patent/DE69832486T2/de not_active Expired - Fee Related
- 1998-05-25 UA UA99126737A patent/UA70298A/uk unknown
- 1998-05-25 AT AT98919414T patent/ATE310742T1/de not_active IP Right Cessation
- 1998-05-25 PL PL98337497A patent/PL337497A1/xx unknown
- 1998-05-25 NZ NZ500652A patent/NZ500652A/en unknown
- 1998-05-25 CN CNB988060493A patent/CN1145636C/zh not_active Expired - Fee Related
- 1998-05-25 HU HU0004076A patent/HUP0004076A3/hu unknown
- 1998-06-04 AP APAP/P/1998/001254A patent/AP1189A/en active
- 1998-06-08 TW TW093111859A patent/TW200418871A/zh unknown
- 1998-06-08 GT GT199800075A patent/GT199800075A/es unknown
- 1998-06-08 PE PE1998000469A patent/PE79999A1/es not_active Application Discontinuation
- 1998-06-08 TW TW087109085A patent/TWI224106B/zh active
- 1998-06-09 MY MYPI98002563A patent/MY133027A/en unknown
- 1998-06-09 AR ARP980102704A patent/AR013085A1/es active IP Right Grant
- 1998-06-10 DZ DZ980125A patent/DZ2515A1/xx active
- 1998-06-10 ZA ZA9805016A patent/ZA985016B/xx unknown
- 1998-06-10 CO CO98033231A patent/CO4950584A1/es unknown
- 1998-06-10 TN TNTNSN98084A patent/TNSN98084A1/fr unknown
- 1998-06-10 MA MA25106A patent/MA24563A1/fr unknown
- 1998-06-11 HR HR60/049,980A patent/HRP980315A2/hr not_active Application Discontinuation
- 1998-06-11 UY UY25041A patent/UY25041A1/es not_active IP Right Cessation
-
1999
- 1999-11-16 IS IS5250A patent/IS1979B/is unknown
- 1999-12-03 OA OA9900270A patent/OA11226A/en unknown
- 1999-12-08 BG BG103969A patent/BG64357B1/bg unknown
- 1999-12-10 NO NO19996107A patent/NO315560B1/no unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE79999A1 (es) | Derivados de macrolidos c-4" sustituidos | |
| PT804200E (pt) | Uso de derivados de noribogaina para tratamento de dependencia quimica em mamiferos | |
| NO904377L (no) | Tricykliske karbapenemforbindelser. | |
| EA200100204A1 (ru) | Фармацевтические агенты для лечения болезни паркинсона, ганв и микроаденом | |
| KR960007592A (ko) | 신규한 피롤로카바졸 | |
| DK0474712T3 (da) | Anvendelse af lysolecitinderivater til fremstilling af et farmaceutisk præparat | |
| CA2306963A1 (en) | Novel 3,6-hemiketals from the class of 9a-azalides | |
| AR247744A1 (es) | Compuestos organosilano y catalizadores que contienen dichos compuestos | |
| FR2387988A1 (fr) | Esters de cefuroxime, leur preparation et leur application therapeutique | |
| ATE56006T1 (de) | Succinimide derivate, herstellung und anwendung. | |
| ATE86860T1 (de) | Praeparat gegen ulcus. | |
| GR3004855T3 (es) | ||
| FR2434167A1 (fr) | Derives de l'hexahydro-1,2,3,3a,8,8a pyrrolo indole (2,3,-b) | |
| KR920007995A (ko) | 벤즈아미드 유도체 | |
| KR900001673A (ko) | N-치환 아미드 유도체 | |
| KR890009901A (ko) | 3-히드록시-2-(4-메톡시페닐)-5-(2-메틸아미노에틸)-2,3-디히드로-5h-1,5- 벤조티아제핀-4-온 유도체, 그의 제조 및 치료에의 이용 | |
| SE8703999D0 (sv) | Antracyklinglykosider med antitumor effekt, framstellning, mellanprodukter, kompositioner och anordning | |
| IE780126L (en) | Thiazoloisoquinoline derivatives | |
| PT96757A (pt) | Processo de preparacao de derivados de indolo e de composicoes farmaceuticas | |
| ES550742A0 (es) | Un procedimiento para la preparacion de una octahidroindo- lizina | |
| AU5455780A (en) | Hexahydro-1,4-oxazepines | |
| ES504259A0 (es) | Procedimiento para la obtencion de nuevos derivados de la tiazolo (3,2-a) pirimidina | |
| EA199900684A1 (ru) | Производные иминоазаантрациклинона для лечения амилоидоза | |
| PE20001429A1 (es) | Derivados de higromicina como agentes antibacterianos | |
| KR920007626A (ko) | 벤조[b]티오펜-2-카르복시이미드아미드 유도체의 사용방법 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| FD | Application declared void or lapsed |